Physician profile
David Dean
NPI 1043282528
$12,914.82
in general payments reported to CMS, 2019-2025
22 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,374 · 2020: $229 · 2021: $68.86 · 2022: $1,460 · 2023: $1,049 · 2024: $5,684 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,084 · Food and Beverage: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,084.47 |
| Food and Beverage | $1,698.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,536.45 | 2019-2025 | Mako, Aequalis Perform |
| Cgg Medical INC | $3,903.76 | 2024 | |
| Arthrex, INC. | $3,394.70 | 2019-2024 | |
| Djo, LLC | $349.42 | 2021-2025 | Cmf |
| Kuros Biosciences USA, INC | $116.84 | 2023 | |
| Depuy Synthes Sales INC. | $103.28 | 2019-2023 | Monovisc, Orthovisc |
| Si-Bone, INC. | $97.05 | 2023 | |
| Dunamis Medical, LLC | $94.22 | 2024 | |
| Flower Orthopedics Coporation | $50.91 | 2024 | |
| Organogenesis INC. | $45.06 | 2025 | Puraply Wound Matrix |
| Nevro Corp. | $34.69 | 2021 | |
| Pacira Therapeutics, INC. | $25.61 | 2019 | |
| Ethicon US, LLC | $25.06 | 2025 | Vistaseal |
| Smith+Nephew, INC. | $19.34 | 2020 | |
| Radius Health, INC. | $17.61 | 2025 | Tymlos |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.54 | 2019 | |
| Bioventus LLC | $15.21 | 2022 | |
| Amgen INC. | $14.91 | 2024 | Prolia, Evenity |
| Orthofix Medical, INC. | $14.56 | 2022 | |
| Pfizer INC. | $13.71 | 2020 | |
| Horizon Therapeutics Plc | $13.11 | 2022 | |
| Vericel Corporation | $12.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.